Many older adults start GLP-1 drugs for diabetes or weight loss but stop within months, often losing the health gains they initially achieved. Studies show discontinuation rates are especially high among people 65 and older, driven by side effects like nausea, loss of muscle mass, drug shortages, high costs and inconsistent Medicare coverage. Policy changes are under consideration, including a potential expansion of Medicare eligibility for obesity treatment.
Full Story: KFF Health News (1/5)